題?? 目：From phosphorus metallo-dendrimers to polycationic dendrimers and dendrons as original nanoplatforms to treat cancers and tuberculosis: Main progress
?報(bào)告人：Serge Mignani 教授
?????? ??????Université Paris Descartes
?時(shí)?? 間：2018年4月10日（星期二）9:30
?地?? 點(diǎn)：四號(hào)學(xué)院樓3083室
?主持人：史向陽(yáng)??教授
?報(bào)告人簡(jiǎn)介：
???? Serge Mignani - Formerly Head of Medicinal Chemistry Department and Scientific Director (Sanofi)- Université Paris Descartes, PRES Sorbonne Paris Cité, CNRS, UMR 860, Laboratoire de Chimie et Biochimie pharmacologiques et toxicologiques, 45 rue des Saints Pères, 75006, Paris, France- CQM - Centro de Química da Madeira, MMRG, Universidade da Madeira, Campus da Penteada, 9020-105 Funchal, Portugal
?報(bào)告內(nèi)容簡(jiǎn)介：
???? The focus of this presentation will be to present and analyze the development of metallo-phosphorus dendrimers as new anticancer agents with original mechanism of action. Based on these anticancer activities, we developed original polycationic phosphorus dendrimers and dendrons as new anticancer agents. Interestingly, several of them, but with different chemical structure, showed antimycobacterial activities as first-in-class agents against tuberculosis. In addition, main structure-activity relationships will be also presented for the different chemical series related to biological activities.
版權(quán)與免責(zé)聲明：本網(wǎng)頁(yè)的內(nèi)容由收集互聯(lián)網(wǎng)上公開(kāi)發(fā)布的信息整理獲得。目的在于傳遞信息及分享，并不意味著贊同其觀點(diǎn)或證實(shí)其真實(shí)性，也不構(gòu)成其他建議。僅提供交流平臺(tái)，不為其版權(quán)負(fù)責(zé)。如涉及侵權(quán)，請(qǐng)聯(lián)系我們及時(shí)修改或刪除。郵箱：sales@allpeptide.com